Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism

Cytokine and Growth Factor Reviews

Volumn 20, Issue 5-6, 2009, Pages 523-531

  Schulz, Tim J ^a   Tseng, Yu Hua ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adipose tissue; Bone morphogenetic proteins; Energy metabolism

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADIPOGENESIS; BODY FAT DISTRIBUTION; CELL DIFFERENTIATION; CELL FATE; ENERGY EXPENDITURE; ENERGY METABOLISM; HUMAN; LIPID STORAGE; MESENCHYMAL STEM CELL; NONHUMAN; OBESITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROADIPOCYTE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; ENERGY METABOLISM; HUMANS; MODELS, BIOLOGICAL;

EID: 70649109834     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2009.10.019     Document Type: Review

References (108)

1. Kopelman P.G. Obesity as a medical problem. Nature 404 6778 (2000) 635-643
2. Hsu I.R., Kim S.P., Kabir M., and Bergman R.N. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 86 3 (2007) s867-s871
3. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 4 2 (2007) 147-152
4. Cornier M.A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., et al. The metabolic syndrome. Endocr Rev 29 7 (2008) 777-822
5. Finkelstein E.A., Trogdon J.G., Cohen J.W., and Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff (Millwood) (2009)
6. Gesta S., Tseng Y.H., and Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell 131 2 (2007) 242-256
7. Friedman J.M. Obesity in the new millennium. Nature 404 6778 (2000) 632-634
8. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27 7 (2006) 762-778
9. Rosen E.D., and Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 7121 (2006) 847-853
10. Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids 73 1 (2005) 9-15
11. Cannon B., and Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 84 1 (2004) 277-359
12. Kissebah A.H., and Krakower G.R. Regional adiposity and morbidity. PMID 74 4 (1994) 761-811
13. Ghorbani M., Claus T.H., and Himms-Hagen J. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem Pharmacol 54 1 (1997) 121-131
14. Guerra C., Koza R.A., Yamashita H., Walsh K., and Kozak L.P. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 102 2 (1998) 412-420
15. Lowell B.B., Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366 6457 (1993) 740-742
16. Lean M.E., James W.P., Jennings G., and Trayhurn P. Brown adipose tissue uncoupling protein content in human infants, children and adults. Clin Sci (Lond) 71 3 (1986) 291-297
17. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360 15 (2009) 1509-1517
18. Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 360 15 (2009) 1500-1508
19. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 360 15 (2009) 1518-1525
20. Saito M., Okamatsu-Ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Nio-Kobayashi J., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58 7 (2009) 1526-1531
21. Zingaretti M.C., Crosta F., Vitali A., Guerrieri M., Frontini A., Cannon B., et al. The presence of UCP-1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J (2009)
22. Hirsch J., and Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5 2 (1976) 299-311
23. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., et al. Dynamics of fat cell turnover in humans. Nature 453 7196 (2008) 783-787
24. Tang W., Zeve D., Suh J., Bosnakovski D., Kyba M., Hammer B., et al. White fat progenitor cells reside in the adipose vasculature. Science (2008)
25. Rodeheffer M.S., Birsoy K., and Friedman J.M. Identification of white adipocyte progenitor cells in vivo. Cell 135 2 (2008) 240-249
26. Timmons J.A., Wennmalm K., Larsson O., Walden T.B., Lassmann T., Petrovic N., et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A 104 11 (2007) 4401-4406
27. Seale P., Bjork B., Yang W., Kajimura S., Chin S., Kuang S., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454 7207 (2008) 961-967
28. Cousin B., Cinti S., Morroni M., Raimbault S., Ricquier D., Penicaud L., et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 103 Pt 4 (1992) 931-942
29. Almind K., Manieri M., Sivitz W.I., Cinti S., and Kahn C.R. Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. Proc Natl Acad Sci U S A 104 7 (2007) 2366-2371
30. Jones D.L., and Wagers A.J. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 9 1 (2008) 11-21
31. Moulin K., Truel N., Andre M., Arnauld E., Nibbelink M., Cousin B., et al. Emergence during development of the white adipocyte cell phenotype is independent of the brown adipocyte cell phenotype. Biochem J 356 Pt 2 (2001) 659-664
32. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 4 4 (2006) 263-273
33. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7 12 (2006) 885-896
34. Smas C.M., and Sul H.S. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73 4 (1993) 725-734
35. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 289 5481 (2000) 950-953
36. Hansen J.B., Jorgensen C., Petersen R.K., Hallenborg P., De Matteis R., Boye H.A., et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A 101 12 (2004) 4112-4117
37. Scime A., Grenier G., Huh M.S., Gillespie M.A., Bevilacqua L., Harper M.E., et al. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. Cell Metab 2 5 (2005) 283-295
38. Tseng Y.H., Butte A.J., Kokkotou E., Yechoor V.K., Taniguchi C.M., Kriauciunas K.M., et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol 7 6 (2005) 601-611
39. Seale P., Kajimura S., Yang W., Chin S., Rohas L.M., Uldry M., et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab 6 1 (2007) 38-54
40. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., and Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 6 (1998) 829-839
41. Picard F., Gehin M., Annicotte J., Rocchi S., Champy M.F., O'Malley B.W., et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111 7 (2002) 931-941
42. Wang Z., Qi C., Krones A., Woodring P., Zhu X., Reddy J.K., et al. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metab 3 2 (2006) 111-122
43. Steel J.H., White R., and Parker M.G. Role of the RIP140 corepressor in ovulation and adipose biology. J Endocrinol 185 1 (2005) 1-9
44. Hansen J.B., and Kristiansen K. Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem J 398 2 (2006) 153-168
45. Lacroix P. Recent investigations on the growth of bone. Nature 156 (1945) 576
46. Urist M.R. Bone: formation by autoinduction. Science 150 698 (1965) 893-899
47. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 4885 (1988) 1528-1534
48. Reddi A.H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16 3 (1998) 247-252
49. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8 2 (1994) 133-146
50. Zhao G.Q. Consequences of knocking out BMP signaling in the mouse. Genesis 35 1 (2003) 43-56
51. Nohe A., Keating E., Knaus P., and Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16 3 (2004) 291-299
52. Xiao Y.T., Xiang L.X., and Shao J.Z. Bone morphogenetic protein. Biochem Biophys Res Commun 362 3 (2007) 550-553
53. Yamamoto Y., and Oelgeschlager M. Regulation of bone morphogenetic proteins in early embryonic development. Naturwissenschaften 91 11 (2004) 519-534
54. Chen D., Zhao M., and Mundy G.R. Bone morphogenetic proteins. Growth Factors 22 4 (2004) 233-241
55. Tseng Y.H., and He T.C. Bone morphogenetic proteins and adipocyte differentiation. Cell Sci Rev 3 3 (2007) 342-360
56. Kishigami S., and Mishina Y. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 16 3 (2005) 265-278
57. Halbrooks P.J., Ding R., Wozney J.M., and Bain G. Role of RGM co-receptors in bone morphogenetic protein signaling. J Mol Signal 2 (2007) 4
58. Nohe A., Hassel S., Ehrlich M., Neubauer F., Sebald W., Henis Y.I., et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277 7 (2002) 5330-5338
59. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., et al. Determinants of specificity in TGF-beta signal transduction. Genes Dev 12 14 (1998) 2144-2152
60. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 6651 (1997) 631-635
61. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., et al. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389 6651 (1997) 622-626
62. Ulloa L., Doody J., and Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397 6721 (1999) 710-713
63. Liu X., Nagarajan R.P., Vale W., and Chen Y. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor. FEBS Lett 519 1-3 (2002) 93-98
64. Kandror K.V. A long search for Glut4 activation. Sci STKE 2003 169 (2003) E5
65. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24 1 (2003) 78-90
66. Kimura N., Matsuo R., Shibuya H., Nakashima K., and Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275 23 (2000) 17647-17652
67. Shibuya H., Iwata H., Masuyama N., Gotoh Y., Yamaguchi K., Irie K., et al. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J 17 4 (1998) 1019-1028
68. Yamaguchi K., Nagai S., Ninomiya-Tsuji J., Nishita M., Tamai K., Irie K., et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18 1 (1999) 179-187
69. de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 15 1 (2004) 1-11
70. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4 1-2 (1978) 7-25
71. Discher D.E., Mooney D.J., and Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 324 5935 (2009) 1673-1677
72. Graff J.M. Embryonic patterning: to BMP or not to BMP, that is the question. Cell 89 2 (1997) 171-174
73. O'Connor M.B., Umulis D., Othmer H.G., and Blair S.S. Shaping BMP morphogen gradients in the Drosophila embryo and pupal wing. Development 133 2 (2006) 183-193
74. Khalsa O., Yoon J.W., Torres-Schumann S., and Wharton K.A. TGF-beta/BMP superfamily members, Gbb-60A and Dpp, cooperate to provide pattern information and establish cell identity in the Drosophila wing. Development 125 14 (1998) 2723-2734
75. Dani C., Smith A.G., Dessolin S., Leroy P., Staccini L., Villageois P., et al. Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 110 Pt 11 (1997) 1279-1285
76. Li X., Schwarz E.M., Zuscik M.J., Rosier R.N., Ionescu A.M., Puzas J.E., et al. Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5. Endocrinology 144 6 (2003) 2514-2523
77. Taha M.F., Valojerdi M.R., and Mowla S.J. Effect of bone morphogenetic protein-4 (BMP-4) on adipocyte differentiation from mouse embryonic stem cells. Anat Histol Embryol 35 4 (2006) 271-278
78. Gimble J.M., Morgan C., Kelly K., Wu X., Dandapani V., Wang C.S., et al. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem 58 3 (1995) 393-402
79. Chen T.L., Shen W.J., and Kraemer F.B. Human BMP-7/OP-1 induces the growth and differentiation of adipocytes and osteoblasts in bone marrow stromal cell cultures. J Cell Biochem 82 2 (2001) 187-199
80. Pereira R.C., Delany A.M., and Canalis E. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 30 5 (2002) 685-691
81. Sciaudone M., Gazzerro E., Priest L., Delany A.M., and Canalis E. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144 12 (2003) 5631-5639
82. Song C., Guo Z., Ma Q., Chen Z., Liu Z., Jia H., et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 308 3 (2003) 458-462
83. Reznikoff C.A., Brankow D.W., and Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33 12 (1973) 3231-3238
84. Taylor S.M., and Jones P.A. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17 4 (1979) 771-779
85. Wang E.A., Israel D.I., Kelly S., and Luxenberg D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9 1 (1993) 57-71
86. Ahrens M., Ankenbauer T., Schroder D., Hollnagel A., Mayer H., and Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12 10 (1993) 871-880
87. Asahina I., Sampath T.K., and Hauschka P.V. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222 1 (1996) 38-47
88. Bachner D., Ahrens M., Schroder D., Hoffmann A., Lauber J., Betat N., et al. Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev Dyn 213 4 (1998) 398-411
89. Butterwith S.C., Wilkie R.S., and Clinton M. Treatment of pluripotential C3H 10T1/2 fibroblasts with bone morphogenetic protein-4 induces adipocyte commitment. Biochem Soc Trans 24 2 (1996) 163S
90. Tang Q.Q., Otto T.C., and Lane M.D. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A 101 26 (2004) 9607-9611
91. Tseng Y.H., Kokkotou E., Schulz T.J., Huang T.L., Winnay J.N., Taniguchi C.M., et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454 7207 (2008) 1000-1004
92. Kalluri R., and Zeisberg M. Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7. Histol Histopathol 18 1 (2003) 217-224
93. Loncar D. Brown adipose tissue as a derivative of mesoderm grafted below the kidney capsule. A model for differentiation of isolated rat mesoderm. Int J Dev Biol 36 2 (1992) 265-274
94. Ji X., Chen D., Xu C., Harris S.E., Mundy G.R., and Yoneda T. Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab 18 3 (2000) 132-139
95. Rebbapragada A., Benchabane H., Wrana J.L., Celeste A.J., and Attisano L. Myostatin signals through a transforming growth factor-beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23 20 (2003) 7230-7242
96. Sottile V., and Seuwen K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 475 3 (2000) 201-204
97. Hata K., Nishimura R., Ikeda F., Yamashita K., Matsubara T., Nokubi T., et al. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor-gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14 2 (2003) 545-555
98. Jin W., Takagi T., Kanesashi S.N., Kurahashi T., Nomura T., Harada J., et al. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. Dev Cell 10 4 (2006) 461-471
99. Koza R.A., Nikonova L., Hogan J., Rim J.S., Mendoza T., Faulk C., et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2 5 (2006) e81
100. Wang W., Yang Y., Meng Y., and Shi Y. GDF-3 is an adipogenic cytokine under high fat dietary condition. Biochem Biophys Res Commun 321 4 (2004) 1024-1031
101. Shen J.J., Huang L., Li L., Jorgez C., Matzuk M.M., and Brown C.W. Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Mol Endocrinol 23 1 (2009) 113-123
102. Lin J., Arnold H.B., Della-Fera M.A., Azain M.J., Hartzell D.L., and Baile C.A. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291 3 (2002) 701-706
103. McPherron A.C., and Lee S.J. Supression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109 5 (2002) 595-601
104. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142 1 (1998) 295-305
105. Sebald W., Nickel J., Zhang J.L., and Mueller T.D. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem 385 8 (2004) 697-710
106. Bottcher Y., Unbehauen H., Kloting N., Ruschke K., Korner A., Schleinitz D., et al. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes (2009)
107. Mishina Y., Suzuki A., Ueno N., and Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9 24 (1995) 3027-3037
108. Schulz T.J., Huang T.L., Mishina Y., and Tseng Y.H. Adipocyte-specific inactivation of type 1A bone morphogenetic protein receptor impacts systemic energy metabolism and fat physiology. Diabetes 58 Supplement 1 (2009)